Literature DB >> 18401572

[Acute ischemic stroke. Diagnostic imaging and interventional options].

J Trenkler1.   

Abstract

Stroke is the third most common cause of death after myocardial infarction and neoplasms in industrialized countries and the most common cause for permanent disability with impairment of an independent life style. In addition to the socioeconomic problems caused by a disabling stroke, it is to be expected that with an increasing average age of the population, the number of stroke patients will increase as well [4]. The need for effective and widely available therapies against this severe disease is highly evident. Diagnostic imaging is indispensable in order to apply these therapies efficiently and precisely. In addition to the established intravenous thrombolytic therapy with rt-PA within the first 3 h, a therapeutic benefit can also be achieved with thrombolysis inside the time-window 3-6 h, whereas the rate of symptomatic intracerebral hemorrhages increases. Local intraarterial fibrinolysis (LIF) within 6 h is effective and safe and may lead to considerable improvement despite an initially severe medical condition [13]. Besides LIF, interventional techniques for mechanical recanalization of intracranial vessel occlusions are becoming increasingly more established. According to international guidelines for the treatment of acute stroke, computed tomography (CT) is considered to be the most important technical diagnostic tool if available round-the-clock. Alternatively, magnetic resonance tomography (MRT) may primarily be performed if carried out without delay and if the imaging protocol contains a sequence suitable for exclusion of hemorrhages.

Entities:  

Mesh:

Year:  2008        PMID: 18401572     DOI: 10.1007/s00117-008-1663-4

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  28 in total

1.  [Multimodal computed tomography in acute cerebral infarction. Experience with a standardized protocol in 100 patients].

Authors:  R Handschu; S Fateh-Moghadam; E Klotz; A Schmid; B Stemper; J G Heckmann; W J Huk; B Neundörfer; B F Tomandl
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

2.  Acute stroke: usefulness of early CT findings before thrombolytic therapy.

Authors:  R von Kummer; K L Allen; R Holle; L Bozzao; S Bastianello; C Manelfe; E Bluhmki; P Ringleb; D H Meier; W Hacke
Journal:  Radiology       Date:  1997-11       Impact factor: 11.105

3.  Computer subtraction in regional cerebral blood-volume measurements using the EMI-Scanner.

Authors:  E Zilkha; G Ladurner; L D Iliff; G H Du Boulay; J Marshall
Journal:  Br J Radiol       Date:  1976-04       Impact factor: 3.039

4.  Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I.

Authors:  W S Smith
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

Review 5.  Alberta Stroke Program Early CT Score in acute stroke triage.

Authors:  Andrew M Demchuk; Shelagh B Coutts
Journal:  Neuroimaging Clin N Am       Date:  2005-05       Impact factor: 2.264

6.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

7.  Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients.

Authors:  Benjamin S Geisler; Frank Brandhoff; Jens Fiehler; Christian Saager; Oliver Speck; Joachim Röther; Hermann Zeumer; Thomas Kucinski
Journal:  Stroke       Date:  2006-06-01       Impact factor: 7.914

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Standardized time to peak in ischemic and regular cerebral tissue measured with perfusion MR imaging.

Authors:  Christian Nasel; Nicole Kronsteiner; Erwin Schindler; Sören Kreuzer; Stephan Gentzsch
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

10.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.